We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
The UK and US signed a Memorandum of Understanding on critical minerals in Washington DC on 4 February.
This page introduces the Participation Survey and links to all relevant documents.
How to use a before-and-after study to evaluate your digital health product.
What you need to know about being part of the Taking Part survey.
How to use a quasi-experimental study to evaluate your digital health product.
This series brings together all statistical releases from the Participation Survey.
Guidance on the collection, verification, and reporting of safety events in clinical trials of an investigational medicinal product.
How to use an interrupted time series to evaluate your digital health product.
How investigators and sponsors should manage clinical trials during COVID-19
Find out how to complete and submit a return using the HMRC spreadsheet or electronic flat text file (EFTF).
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).